Freestone Grove Partners’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,337,777
Closed -$23.6M 1005
2026
Q1
$23.6M Buy
1,337,777
+717,567
+116% +$14.4M 0.17% 192
2025
Q4
$12.2M Sell
620,210
-587,777
-49% -$10.6M 0.09% 266
2025
Q3
$21.1M Buy
1,207,987
+663,641
+122% +$9.84M 0.16% 201
2025
Q2
$7.62M Buy
+544,346
New +$8.76M 0.06% 304
2025
Q1
Sell
-177,614
Closed -$2M 578
2024
Q4
$2M Buy
+177,614
New +$2.08M 0.02% 266

Other funds holding ALHC

Freestone Grove Partners's ALHC Position: Q2 2026 in Review

Freestone Grove Partners sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 1,337,777 shares — an estimated $23.6M sold.

Freestone Grove Partners first reported a position in ALHC in Q4 2024 and held it in 5 quarters. The position peaked at $23.6M in Q1 2026. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Freestone Grove Partners reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 1,337,777 Alignment Healthcare shares in Q2 2026, an estimated $23.6M.
  • Freestone Grove Partners first reported a position in Alignment Healthcare in Q4 2024 and held it in 5 quarters.
  • Freestone Grove Partners's Alignment Healthcare position peaked at $23.6M in Q1 2026.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.